查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829303

2025年全球主動脈內皮移植市場報告

Aortic Endograft Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，主動脈內皮移植市場規模強勁成長，從2024年的33.5億美元增加至2025年的35.2億美元，複合年成長率為5.4%。預測期內的成長歸因於醫療旅遊業的成長、主動脈瘤管理需求的增加、主動脈瘤病例數量的增加、內皮移植技術的成功以及醫院數量的增加。

預計未來幾年主動脈內皮移植市場將穩定成長，到2029年將達到42.8億美元，年複合成長率（CAGR）為5.0%。預測期內的成長受多種因素驅動，例如腹部主動脈血管瘤盛行率的上升、對微創血管內治療的日益偏好、人口老化、血管支架材料和結構的進步以及新型血管支架產品的推出。預測期內的主要趨勢包括血管腹部主動脈血管瘤(AAA)修復器械的普及、一體式和非一體式主動脈支架的有效性以及產品創新。

主動脈內皮移植，也稱為血管內血管支架，是一種微創醫療設備，用於修復主動脈（將血液從心臟輸送到身體其他部位的主要動脈）的薄弱部位。該裝置是治療主動脈瘤的傳統開放性手術的替代方案。

主動脈內移植物的主要類型包括腹主動脈移植物和胸主動脈移植物。腹主動脈移植物專門植入腹主動脈，透過加強薄弱的動脈壁來治療動脈瘤。這些移植物由金屬和聚合物等材料製成，可透過開放性手術或血管內動脈瘤修復術 (EVAR) 進行修復。主動脈內移植物常用於醫院和門診手術中心等醫療機構。

2025年春季，美國關稅飆升及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 最新系列報告之一，提供主動脈內皮移植市場統計數據，包括全球市場規模、各地區市場佔有率、競爭對手的市場佔有率、主動脈內皮移植市場細分、市場趨勢和商業機會，提供在主動脈內皮移植行業取得成功所需的數據。本研究報告詳細分析了主動脈內皮移植行業的現狀和未來趨勢，為您提供所需的一切資訊，提供全面的展望。

我們預測未來五年該市場將成長5.0%，較先前預測略有下降0.2%。這一下降主要源自於美國與其他國家之間關稅的影響。美國將直接感受到這一影響，因為義大利製造的聚酯纖維移植物和荷蘭製造的滲透性標記系統供應減少，可能會延誤挽救生命的動脈瘤修復手術。此外，由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這一影響也將更加廣泛地蔓延。

主動脈瘤盛行率的不斷上升預計將在短期內推動主動脈內皮移植市場的成長。主動脈瘤的特徵是主動脈（人體最大的動脈）異常擴張，主動脈內移植物是有效治療主動脈瘤的方法，與傳統開放性手術相比，主動脈內移植物以微創性而聞名。這些裝置通常由織物覆蓋的金屬或聚合物組成，透過導管插入以加強薄弱的主動脈壁並降低破裂風險。值得注意的是，2023 年 2 月，英國政府數位服務部的數據顯示，約有 274,800 名男性接受了篩檢，其中 79.0% 獲得了結論性結果，在 2021 年 4 月至 2022 年 3 月期間檢測到 1,794 個動脈瘤。這證實了主動脈瘤盛行率的不斷上升是主動脈內皮移植市場擴張的驅動力。

主動脈內皮移植市場的關鍵參與企業正在開發創新解決方案，例如 Castor 分支主動脈血管支架系統，以增強其在產業中的競爭地位。 Castor 分支主動脈血管支架系統是醫療設備，旨在對主動脈和主動脈弓進行微創修復，尤其適用於史丹佛 B 型主動脈剝離 (TBAD)。例如，2024 年 8 月， Terumo Corporation Corporation 的印度子公司、重要的醫療技術公司Terumo Corporation India 推出了 TREO血管支架系統，這是一種用於血管內動脈瘤修復 (EVAR) 的創新解決方案。此先進系統旨在治療具有適當解剖結構的成人腎內腹部主動脈血管瘤，並且是唯一提供腎臟上和腎臟下主動固定的 EVAR 移植。

2022年9月，總部位於瑞典的醫療技術和生命科學設備專家潔定 (Getinge) 與Medtronic)達成合作，此前Medtronic的Radiant覆膜支架獲得CE標誌核准。此次合作符合潔定的策略，即為煙囪型血管內動脈瘤修復術 (ChEVAR) 等複雜的主動脈修復手術提供全面的解決方案，旨在為臨床醫生提供這些先進治療的完整方案。Medtronic總部位於愛爾蘭，是一家領先的醫療技術和醫療保健解決方案公司。

主動脈內皮移植市場報告中介紹的主要企業包括 Cardinal Health Inc.、Abbott Laboratories、Medtronic Plc、Becton, Dickinson and Company、Koninklijke Philips NV、Boston Scientific Corporation、Terumo Corporation、W.L. Gore & Associates Inc.、Cook Medical Inc.、Meritific Systems Inc. Inc.、MicroPort Scientific Corporation、CryoLife Inc.、Cordis Corporation、Endologix LLC、Braille Biomedica Industria Comercio e Representacoes Ltda.、Nano Endoluminal SA、Biomerics LLC、JOTEC GmbH、Lombard Medicalation Inc.、Aptus Endosystems Inc.、Lombs Technologies、Achitis. Trans.

2024年，主動脈內皮移植市場最大的地區是北美。預計亞太地區將成為預測期內成長最快的地區。主動脈內皮移植市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

主動脈內皮移植市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、美國、英國、加拿大、義大利和西班牙。

主動脈內皮移植市場由各營業單位透過培訓計畫、教育服務以及維護和支持服務產生的收益所構成。市場規模包括服務供應商銷售或包含在其服務產品中的相關產品的價值。主動脈內皮移植市場還包括端錨和密封劑的銷售。該市場的價值為“出廠價”，即產品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的產品價值。該市場中的產品價值還包括產品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球主動脈內皮移植：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球主動脈內皮移植市場：成長率分析
  • 全球主動脈內皮移植市場表現：規模與成長，2019-2024
  • 全球主動脈內皮移植市場預測：規模與成長，2024-2029年，2034年
  • 全球主動脈內皮移植：總目標市場（TAM）

第6章 市場細分

  • 全球主動脈內皮移植市場（依產品、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 腹主動脈移植
  • 胸主動脈移植
  • 全球主動脈內皮移植市場（按材料、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 金屬內移植物
  • 聚合物內移植物
  • 全球主動脈內皮移植市場（依手術類型、表現及預測），2019-2024 年、2024-2029 年、2034 年
  • 開放性手術修復
  • 血管內動脈瘤修復術（EVAR）
  • 全球主動脈內皮移植市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 全球主動脈內皮移植市場：腹主動脈移植細分市場、類型、績效及預測（2019-2024、2024-2029、2034）
  • 開窗主動脈移植物
  • 分支主動脈移植物
  • 傳統主動脈移植
  • 全球主動脈內皮移植市場：胸主動脈移植細分市場、類型、績效及預測（2019-2024、2024-2029、2034）
  • 附支架胸主動脈移植物
  • 無支架胸主動脈移植物
  • 混合胸主動脈移植

第7章 區域和國家分析

  • 全球主動脈內皮移植市場：依地區、績效及預測，2019-2024年、2024-2029年、2034年
  • 全球主動脈內皮移植市場：國家、績效及預測（2019-2024、2024-2029、2034）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 主動脈內皮移植市場：競爭格局
  • 主動脈內皮移植市場：公司簡介
    • Cardinal Health Inc.
    • Abbott Laboratories
    • Medtronic Plc
    • Becton, Dickinson and Company
    • Koninklijke Philips NV

第31章：其他領先和創新企業

  • Boston Scientific Corporation
  • Terumo Corporation
  • WL Gore & Associates Inc.
  • Cook Medical Inc.
  • Merit Medical Systems Inc.
  • Penumbra Inc.
  • LifeTech Scientific Corporation
  • Altura Medical Inc.
  • MicroVention Inc.
  • MicroPort Scientific Corporation
  • CryoLife Inc.
  • Cordis Corporation
  • Endologix LLC
  • Braile Biomedica Industria Comercio e Representacoes Ltda.
  • Nano Endoluminal SA

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年主動脈內皮移植市場：提供新機會的國家
  • 2029年主動脈內皮移植市場：細分市場帶來新機會
  • 2029年主動脈內皮移植市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r27347u

An aortic endograft, also known as an endovascular stent graft, is a minimally invasive medical device designed to repair weakened areas of the aorta, the primary artery responsible for transporting blood from the heart to the rest of the body. This device serves as an alternative to traditional open surgery for treating aortic aneurysms.

The primary categories of aortic endografts include abdominal aortic grafts and thoracic aortic grafts. Abdominal aortic grafts are specifically implanted in the abdominal aorta to address aneurysms by reinforcing weakened arterial walls. These devices can be made from materials such as metallic endografts and polymeric endografts, and the procedures involved include open surgical repair and endovascular aneurysm repair (EVAR). Aortic endografts are commonly utilized in medical settings, including hospitals and ambulatory surgical centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The aortic endografts market research report is one of a series of new reports from The Business Research Company that provides aortic endografts market statistics, including aortic endografts industry global market size, regional shares, competitors with aortic endografts market share, detailed aortic endografts market segments, market trends, and opportunities, and any further data you may need to thrive in the aortic endografts industry. This aortic endografts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The aortic endograft market size has grown strongly in recent years. It will grow from $3.35 billion in 2024 to $3.52 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to growth in medical tourism, increasing need for aortic aneurysm management, increasing number of aortic aneurysm cases, technical success of endograft implantation, increase in the number of hospitals.

The aortic endograft market size is expected to see steady growth in the next few years. It will grow to $4.28 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to increasing prevalence of abdominal aortic aneurysm, growing preference for minimally invasive endovascular procedures, rising geriatric population, advancements in stent-graft materials and configurations, introduction of new stent-graft products. Major trends in the forecast period include adoption of endovascular abdominal aortic aneurysm (AAA) repair devices, effectiveness of unibody and non-unibody aortic stent, product innovation.

The forecast of 5.0% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through reduced availability of woven polyester grafts from Italy and radiopaque marker systems from the Netherlands, potentially delaying life-saving aneurysm repairs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of aortic aneurysms is anticipated to drive the growth of the aortic endograft market in the foreseeable future. Aortic aneurysms, characterized by abnormal dilation of the aorta, the body's largest artery, are effectively treated using aortic endografts, known for their minimally invasive nature compared to traditional open surgery. These devices, typically composed of fabric-covered metal or polymer, are introduced through a catheter, reinforcing weakened aortic walls and reducing the risk of rupture. Notably, in February 2023, data from the UK-based Government Digital Service revealed that approximately 274,800 men underwent screening, with 79.0% receiving conclusive results and the detection of 1,794 aneurysms between April 2021 and March 2022. This underscores the driving force of the growing prevalence of aortic aneurysms in fostering the expansion of the aortic endograft market.

Key players in the aortic endograft market are developing innovative solutions, such as the castor-branched aortic stent graft system, to enhance their competitive position in the industry. The castor-branched aortic stent graft system is a medical device designed for minimally invasive repair of the aorta and aortic arch, particularly for Stanford type B aortic dissection (TBAD). For example, in August 2024, Terumo India, a significant medical technology company and the Indian subsidiary of Terumo Corporation, introduced the TREO Stent-Graft System, an innovative solution for Endovascular Aneurysm Repair (EVAR). This advanced system is intended for treating infrarenal abdominal aortic aneurysms in adults with suitable anatomies and is the only EVAR graft that provides both suprarenal and infrarenal active fixation.

In September 2022, Getinge, a Sweden-based company specializing in medical technology and life sciences equipment, formed a partnership with Medtronic after the CE mark approval for Medtronic's Radiant covered stent. This collaboration is in line with Getinge's strategy to provide comprehensive solutions for complex aortic repair procedures, such as chimney endovascular aneurysm repair (ChEVAR), and aims to offer clinicians a complete package for these advanced treatments. Medtronic, based in Ireland, is a leading player in medical technology and healthcare solutions.

Major companies operating in the aortic endograft market report are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton, Dickinson and Company, Koninklijke Philips N.V., Boston Scientific Corporation, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., Merit Medical Systems Inc., Penumbra Inc., LifeTech Scientific Corporation, Altura Medical Inc., MicroVention Inc., MicroPort Scientific Corporation, CryoLife Inc., Cordis Corporation, Endologix LLC, Braile Biomedica Industria Comercio e Representacoes Ltda., Nano Endoluminal S.A., Biomerics LLC, JOTEC GmbH, Lombard Medical Inc., Aptus Endosystems Inc., Lombardi SA, Cardiatis S.A., Endospan Ltd., Transcatheter Technologies GmbH

North America was the largest region in the aortic endograft market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic endograft market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the aortic endograft market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The aortic endograft market consists of revenues earned by entities by training programs, educational services, maintenance, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The aortic endograft market also includes sales of endoanchors and sealants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Aortic Endograft Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aortic endograft market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for aortic endograft ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The aortic endograft market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Abdominal Aortic Grafts; Thoracic Aortic Grafts
  • 2) By Material: Metallic Endografts; Polymeric Endografts
  • 3) By Procedure: Open Surgical Repair; Endovascular Aneurysm Repair (EVAR)
  • 4) By End User: Hospitals; Ambulatory Surgical Centers
  • Subsegments:
  • 1) By Abdominal Aortic Grafts: Fenestrated Aortic Grafts; Branched Aortic Grafts; Conventional Aortic Grafts
  • 2) By Thoracic Aortic Grafts: Stented Thoracic Aortic Grafts; Non-Stented Thoracic Aortic Grafts; Hybrid Thoracic Aortic Grafts
  • Companies Mentioned: Cardinal Health Inc.; Abbott Laboratories; Medtronic Plc; Becton, Dickinson and Company; Koninklijke Philips N.V.; Boston Scientific Corporation; Terumo Corporation; W. L. Gore & Associates Inc.; Cook Medical Inc.; Merit Medical Systems Inc.; Penumbra Inc.; LifeTech Scientific Corporation; Altura Medical Inc.; MicroVention Inc.; MicroPort Scientific Corporation; CryoLife Inc.; Cordis Corporation; Endologix LLC; Braile Biomedica Industria Comercio e Representacoes Ltda.; Nano Endoluminal S.A.; Biomerics LLC; JOTEC GmbH; Lombard Medical Inc.; Aptus Endosystems Inc.; Lombardi SA; Cardiatis S.A.; Endospan Ltd.; Transcatheter Technologies GmbH
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Aortic Endograft Market Characteristics

3. Aortic Endograft Market Trends And Strategies

4. Aortic Endograft Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Aortic Endograft Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Aortic Endograft PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Aortic Endograft Market Growth Rate Analysis
  • 5.4. Global Aortic Endograft Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Aortic Endograft Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Aortic Endograft Total Addressable Market (TAM)

6. Aortic Endograft Market Segmentation

  • 6.1. Global Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Abdominal Aortic Grafts
  • Thoracic Aortic Grafts
  • 6.2. Global Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metallic Endografts
  • Polymeric Endografts
  • 6.3. Global Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Open Surgical Repair
  • Endovascular Aneurysm Repair (EVAR)
  • 6.4. Global Aortic Endograft Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • 6.5. Global Aortic Endograft Market, Sub-Segmentation Of Abdominal Aortic Grafts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Fenestrated Aortic Grafts
  • Branched Aortic Grafts
  • Conventional Aortic Grafts
  • 6.6. Global Aortic Endograft Market, Sub-Segmentation Of Thoracic Aortic Grafts, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stented Thoracic Aortic Grafts
  • Non-Stented Thoracic Aortic Grafts
  • Hybrid Thoracic Aortic Grafts

7. Aortic Endograft Market Regional And Country Analysis

  • 7.1. Global Aortic Endograft Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Aortic Endograft Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Aortic Endograft Market

  • 8.1. Asia-Pacific Aortic Endograft Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Aortic Endograft Market

  • 9.1. China Aortic Endograft Market Overview
  • 9.2. China Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Aortic Endograft Market

  • 10.1. India Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Aortic Endograft Market

  • 11.1. Japan Aortic Endograft Market Overview
  • 11.2. Japan Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Aortic Endograft Market

  • 12.1. Australia Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Aortic Endograft Market

  • 13.1. Indonesia Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Aortic Endograft Market

  • 14.1. South Korea Aortic Endograft Market Overview
  • 14.2. South Korea Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Aortic Endograft Market

  • 15.1. Western Europe Aortic Endograft Market Overview
  • 15.2. Western Europe Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Aortic Endograft Market

  • 16.1. UK Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Aortic Endograft Market

  • 17.1. Germany Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Aortic Endograft Market

  • 18.1. France Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Aortic Endograft Market

  • 19.1. Italy Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Aortic Endograft Market

  • 20.1. Spain Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Aortic Endograft Market

  • 21.1. Eastern Europe Aortic Endograft Market Overview
  • 21.2. Eastern Europe Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Aortic Endograft Market

  • 22.1. Russia Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Aortic Endograft Market

  • 23.1. North America Aortic Endograft Market Overview
  • 23.2. North America Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Aortic Endograft Market

  • 24.1. USA Aortic Endograft Market Overview
  • 24.2. USA Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Aortic Endograft Market

  • 25.1. Canada Aortic Endograft Market Overview
  • 25.2. Canada Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Aortic Endograft Market

  • 26.1. South America Aortic Endograft Market Overview
  • 26.2. South America Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Aortic Endograft Market

  • 27.1. Brazil Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Aortic Endograft Market

  • 28.1. Middle East Aortic Endograft Market Overview
  • 28.2. Middle East Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Aortic Endograft Market

  • 29.1. Africa Aortic Endograft Market Overview
  • 29.2. Africa Aortic Endograft Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Aortic Endograft Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Aortic Endograft Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Aortic Endograft Market Competitive Landscape And Company Profiles

  • 30.1. Aortic Endograft Market Competitive Landscape
  • 30.2. Aortic Endograft Market Company Profiles
    • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

31. Aortic Endograft Market Other Major And Innovative Companies

  • 31.1. Boston Scientific Corporation
  • 31.2. Terumo Corporation
  • 31.3. W. L. Gore & Associates Inc.
  • 31.4. Cook Medical Inc.
  • 31.5. Merit Medical Systems Inc.
  • 31.6. Penumbra Inc.
  • 31.7. LifeTech Scientific Corporation
  • 31.8. Altura Medical Inc.
  • 31.9. MicroVention Inc.
  • 31.10. MicroPort Scientific Corporation
  • 31.11. CryoLife Inc.
  • 31.12. Cordis Corporation
  • 31.13. Endologix LLC
  • 31.14. Braile Biomedica Industria Comercio e Representacoes Ltda.
  • 31.15. Nano Endoluminal S.A.

32. Global Aortic Endograft Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aortic Endograft Market

34. Recent Developments In The Aortic Endograft Market

35. Aortic Endograft Market High Potential Countries, Segments and Strategies

  • 35.1 Aortic Endograft Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Aortic Endograft Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Aortic Endograft Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer